# Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets

> **NCT06558058** · PHASE1 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rivaroxaban 10 mg film-coated tablet
- **DRUG:** Xarelto 10 mg film-coated tablet

## Key facts

- **NCT ID:** NCT06558058
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-08
- **Primary completion:** 2023-06-16
- **Final completion:** 2023-08-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558058, "Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06558058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*